Pharmaceutical researchers cannot convert raw data into clinically valid evidence fast enough for drug development timelines

Drug development teams are drowning in data but lack the tools and processes to extract meaningful evidence from it—losing months or years translating datasets into actionable insights. Researchers struggle to preserve context, relationships, and meaning across disparate data sources, causing delays in critical decision-making and slowing time-to-market for life-saving drugs. Existing data management solutions treat this as a volume problem when the real bottleneck is evidence synthesis and validation.